Economic evaluations of cancer immunotherapy: a systematic review and quality evaluation.

ABSTRACT:

Objectives

Scientific advances in the last decade have highlighted the use of immunotherapy, especially immune checkpoint inhibitors, to be an effective strategy in cancer therapy. However, these immunotherapeutic agents are expensive, and their use must take into account economic criteria. Thus, the objective of the present study was to systematically identify and review published EE related to the use of ipilimumab, nivolumab or pembrolizumab in melanoma, lung cancer, head and neck cancer or renal cell carcinoma, and to assess their quality.

Methods

The systematic literature research was conducted on Medline via PubMed and the Cochrane Central Register of Controlled Trials to identify economic evaluations published before July 2018. The quality of each selected economic ev

SUBMITTER: Couchoud C 

PROVIDER: S-EPMC11027639 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature